Systematic Review
Published on 07 Oct 2025
Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
in Dermatology
- 467 views